.

Deeper Knowledge, Faster

  • Plan your formulary budget
  • Find suppliers and generic API sources
  • Uncover prior art in expired and abandoned patents

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

US Department of Justice
AstraZeneca
Novartis
Cerilliant
Chinese Patent Office
Boehringer Ingelheim
Chubb
Express Scripts
Harvard Business School
Argus Health

Generated: June 25, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 071697

« Back to Dashboard
NDA 071697 describes DOXEPIN HYDROCHLORIDE, which is a drug marketed by Sun Pharm Inds, Par Pharm, Purepac Pharm, Teva Pharms, Wockhardt, Silarx, Pharm Assoc, Sandoz, Watson Labs, Quantum Pharmics, Mylan Pharms Inc, Actavis Elizabeth, Dava Pharms Inc, New River, and Watson Labs Teva, and is included in fifty-five NDAs. It is available from twenty-three suppliers. Additional details are available on the DOXEPIN HYDROCHLORIDE profile page.

The generic ingredient in DOXEPIN HYDROCHLORIDE is doxepin hydrochloride. There are seven drug master file entries for this compound. Twenty-seven suppliers are listed for this compound. Additional details are available on the doxepin hydrochloride profile page.

Summary for NDA: 071697

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:1
Therapeutic Class:Antidepressants
Anxiolytics
Dermatological Agents
Formulation / Manufacturing:see details

Pharmacology for NDA: 071697

Suppliers and Packaging for NDA: 071697

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
DOXEPIN HYDROCHLORIDE
doxepin hydrochloride
CAPSULE;ORAL 071697 ANDA Physicians Total Care, Inc. 54868-2317 54868-2317-0 10 CAPSULE in 1 BOTTLE, PLASTIC (54868-2317-0)
DOXEPIN HYDROCHLORIDE
doxepin hydrochloride
CAPSULE;ORAL 071697 ANDA Physicians Total Care, Inc. 54868-2317 54868-2317-2 60 CAPSULE in 1 BOTTLE (54868-2317-2)

Summary for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:CAPSULE;ORALStrengthEQ 10MG BASE
Approval Date:Nov 9, 1987TE:RLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Novartis
Teva
US Department of Justice
McKesson
Merck
Cerilliant
Medtronic
AstraZeneca
Fish and Richardson
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot